"We Envision Growth Strategies Most Suited
to Your Business"
Clinical analytics platforms are designed to ingest, normalize, and provide actionable insights into various data sources (eHR / EMR, claims, labs & imaging, pharmacy, and growing numbers of social determinants of health (SDoH)/remote monitoring) available on a per-client basis. The platform will typically have the following components: data layer; interconnectivity/connectors; analytics (to provide predictive/preventive recommendations); governance/security; and workflow applications. The market for these platforms is experiencing rapid growth due to the rapid growth and use of AI/ML, i.e., predictive analytics, within clinical analytics platforms.
Powered by these developments, Fortune Business Insights suggests that the clinical analytics platforms industry achieved USD 12.55 billion in 2025. It is estimated to reach USD 35.26 billion by 2034, with a remarkable CAGR of 12.43% over the forecast period.
Headquartered in the U.S., Oracle Corporation is a leading global technology company, recognized for its software and systems used for managing enterprises, with a focus on cloud computing (OCI) and database management. With its combination of database management solutions, artificial intelligence, enterprise resource planning (ERP), and other technologies. Oracle’s products support enterprise IT systems across all industries, including large corporations and non-profit organizations, and Oracle competes in the cloud sector as a large provider of technology services, including Java and MySQL.
In October 2024, the company introduced Oracle Analytics Intelligence for Life Sciences, a cloud-based data and analytics platform that is powered by AI to assist businesses in accelerating the generation of insights. It also provides a single intelligent workstation for disparate data sources to help users conduct multidisciplinary research and generate insights, and to connect that information back to their Oracle Health and Life Sciences ecosystem.
Headquartered in the U.S., Epic Systems Corporation is one of the largest healthcare software companies. Created in 1979, the company has developed Electronic Health Records (EHR) for healthcare organizations (including hospitals, clinics, and integrated networks) to manage patient information, enhance workflows, and increase quality of care through their integrated system and the MyChart patient portal.
In August 2025, Epic Systems was developing 200 AI features to provide intelligent assistance for both patients and healthcare providers. Among the most innovative features is the addition of the AI assistant, Emmie to the MyChart patient portal. Emmie provides users with answers to questions regarding laboratory tests, makes recommendations about screening exams, and facilitates appointment scheduling.
Headquartered in the U.S., Health Catalyst, Inc. is a prominent provider of analytics tools and solutions for healthcare organizations, as well as predictive modeling technology through predictive modeling tools and analytics solutions delivered via the internet. The company partnered with UnityPoint Health to migrate to the company’s next-generation platform, ignite™, as an integral part of UnityPoint’s modernization initiative to provide patients with enhanced access and quality of care.
The next-generation platform builds upon the strong tradition of innovation established by the original data analytics platform (DACP) while continuing to support UnityPoint Health’s mission of improving patient health outcomes through evidence-based medicine.
Innovaccer is a leading supplier for clinical analytics platforms, headquartered in the U.S., which uses an AI engine sourced by an Activator Platform (AP) to combine several patient records into one integrated patient data for healthcare organizations that allows them to improve outcomes in their clinical and financial workflows.
On October 14, 2025, Innovaccer introduced Galaxy, an AI-enabled, full-service platform able to completely transform payers’ management of Risk Adjustment and HEDIS within both Fee-for-Service models and Value Based care. Galaxy connects separated capabilities of Risk and Quality into a single intelligent platform, providing specialized AI-agents and interoperable data architecture to manage an organization’s complex regulatory and financial assets.
Arcadia Solutions, LLC, is a health-tech analytics company, headquartered in the U.S. The company has been providing their cloud-based software to healthcare players and ACOs to enhance their financial and clinical outcomes for patient data aggregation. Arcadia gathers information about every industry into one easy-to-use, adaptable health data platform.
In November 2024, Arcadia unveiled two innovative solutions, Enhanced Benchmarks and Arcadia Vista Push, to improve value-based core performance and provide actionable insights for healthcare organizations. Additionally, the company provided a proposed product roadmap that paves way for further advancements in healthcare analytics.
Veradigm, headquartered in the U.S., is a healthcare information technology company. With their integrated technology and services, the company provides life sciences, health plans, and healthcare providers with the clinical insights necessary to provide the patient efficient care. Veradigm offers a combination of point-of-care clinical and financial solutions, an open commitment to interoperability, and industry-standard expertise.
In January 2026, Veradigm and Meperia (now part of Genesis Automation Healthcare), a healthcare supply chain technology company specializing in AI-powered content and spend management solutions, announced a strategic collaboration to launch a next-generation Electronic Data Interchange (EDI) solution, purpose-built for healthcare.
With corporate headquarters in the U.S., SAS Institute Inc. (known as SAS) is an international provider of analytics and AI software. SAS's software assists organizations in obtaining trustworthy conclusions about their performance based on large datasets using advanced analytics and artificial intelligence. The software supports many industries, including Financial Services, Healthcare, Education, Retailing, Transportation, and Government.
In November 2025, SAS Institute Inc. announced the availability of SAS Clinical Acceleration as an alternative product offering to its customer base. Currently, SAS Clinical Acceleration is the primary solution offered by SAS that leverages SAS® Viya® technology to help improve clinical trials' speed-to-market, data management, analysis, and regulatory submission processes in the life sciences industry.
Truveta was formed from an alliance of U.S. healthcare providers offering a large and varied collection of anonymized data from more than 100 million patients. The company is headquartered in the U.S. Truveta's mission is to "Save Lives with Data" by expediting the process of making new medical advancements, enhancing the clinical trial process, and training AI.
In January 2026, Truveta introduced an innovative way for life sciences to use their proprietary data with real-world daily clinical data called Truveta Live Link. This tool allows life sciences to create forward-looking studies and to generate much more comprehensive, regulatory-grade evidence.
Snowflake Inc., headquartered in the U.S., is a fully managed, cloud-native Data Cloud platform that enables organizations to store, process, and analyze massive datasets. It separates storage from compute, allowing for independent, on-demand scaling across major providers (AWS, Azure, GCP). Key features include AI-powered analytics, data sharing, and robust security.
eClinical Solutions LLC announced a partnership with Snowflake to assist life science organizations in being able to handle increasing amounts of data coming from various sources and leverage the benefits of a new clinical data architecture. The eClinical’s elluminate Clinical Data Intelligence Platform has been fully integrated into the Snowflake AI Data Cloud, to improve the flow of clinical data in regulated settings.
Databricks is a leading data and AI company founded in 2013. Headquartered in the U.S., it offers a unified Data Intelligence Platform designed to handle data engineering, SQL analytics, and AI/ML workloads on a single platform, serving over 15,000 organizations.
In June 2025, Databricks is providing Synapxe, Singapore’s national health technology agency, with a cloud-based analytics platform called “Healix” for the public health system in Singapore as a collaborative project. Databricks and Synapxe have entered into a memorandum of understanding (MoU). The purpose of the MoU is to collaborate on developing new ways of innovating healthcare solutions, developing future data, and AI professionals for the healthcare sector in Singapore.
The development of clinical analytics platforms will be driven by the continued expansion of AI and ML into clinical analytics, which will allow the use of more reliable predicted insights, earlier diagnosis of diseases, and the development of personalized/individualized treatment plans and care; the increasing focus on real-world evidence (RWE); the introduction of more decentralized and virtual trials; the improved ability of clinical analytics systems to interoperate via cloud technology; and the increased popularity and access to conversational AI technologies that allow for more intuitive use of clinical data systems, resulting in better outcomes and reduced cost per patient through more efficient patient-centric care.
+1 833 909 2966 ( Toll Free ) (US)
sales@fortunebusinessinsights.com